Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.34 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18734801 | 1.00 | HDAC2 (0.36) | HDAC2CYP2C9KMT2AMEN1POLB | |
| SCHEMBL18735203 | 0.92 | ITGB1 (0.35) | HDAC2CYP2C9POLBITGB1ITGA4 | |
| SCHEMBL17164976 | 0.92 | HDAC2 (0.39) | HDAC2CYP2C9KMT2AMEN1POLB | |
| SCHEMBL17164977 | 0.92 | HDAC2 (0.39) | HDAC2CYP2C9KMT2AMEN1POLB | |
| SCHEMBL18735088 | 0.89 | HDAC2 (0.36) | HDAC2CYP2C9KMT2APOLB | |
| SCHEMBL18720196 | 0.86 | ITGB1 (0.41) | HDAC2KMT2APOLBITGB1ITGA4 | |
| SCHEMBL14693833 | 0.84 | ITGB1 (0.46) | HDAC2CYP2C9ITGB1ITGA4 | |
| SCHEMBL14693834 | 0.84 | ITGB1 (0.46) | HDAC2CYP2C9ITGB1ITGA4 | |
| SCHEMBL18735061 | 0.83 | KMT2A (0.46) | CYP2C9KMT2APOLB | |
| SCHEMBL18735063 | 0.81 | KMT2A (0.50) | CYP2C9KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017060400-A1 | PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS | NEUROVIVE PHARMACEUTICAL AB (SE) | 2017-04-13 | — | — | WO | disclosed |